Tretinoin does not cause facial hair growth. It is a topical retinoid used primarily to treat acne and signs of photoaging, and it typically reduces sebum production and normalizes follicular keratinization. Any perceived increase in facial hair is likely due to misinterpretation of existing hair or unrelated hormonal changes.
Tretinoin is derived from vitamin A and functions by binding to retinoic acid receptors in skin cells. This interaction accelerates cell turnover, prevents clogged pores, and improves collagen synthesis. Its effects are localized to the epidermis and upper dermis, with minimal systemic absorption. Because it acts on keratinocytes and sebocytes-not hair follicle stem cells-it lacks the mechanism to stimulate new hair growth.
According to the American Academy of Dermatology, tretinoin is not associated with hypertrichosis (excessive hair growth) in clinical trials. The FDA-approved labeling for Retin-A (tretinoin) lists skin irritation, dryness, and peeling as common side effects, but not increased hair growth. In rare cases, patients report temporary changes in hair texture or density during early use, but these resolve with continued application or discontinuation.
Tretinoin alters the structure and function of pilosebaceous units-the unit formed by a hair follicle and sebaceous gland. It reduces sebum secretion by shrinking sebaceous glands and preventing abnormal keratin buildup in follicular openings. This action clears comedones and reduces inflammatory lesions in acne.
While tretinoin influences the follicular environment, it does not activate dormant hair follicles. Hair growth is regulated by androgens, insulin-like growth factor-1 (IGF-1), and local signaling molecules such as Wnt and BMP. Tretinoin does not modulate these pathways in a way that promotes follicular neogenesis or elongation.
A 2019 study published in the Journal of Clinical and Aesthetic Dermatology analyzed 126 patients using 0.025% tretinoin cream daily for six months. Researchers found no statistically significant change in facial hair density or thickness. Some patients reported mild itching or flaking, but none developed new terminal hair growth on the cheeks or jawline.
Some users report seeing "new" hair after starting tretinoin. This is often not actual growth but rather the emergence of fine vellus hairs that were previously hidden beneath dead skin cells. As tretinoin exfoliates the stratum corneum, it reveals these hairs, creating the illusion of increased growth.
Another source of confusion is the similarity between tretinoin and minoxidil. Minoxidil is FDA-approved for treating androgenetic alopecia and stimulates hair follicles through potassium channel activation. Tretinoin has no such effect. Mixing up the two leads to incorrect assumptions about outcomes.
Some individuals experience hormonal fluctuations during treatment-especially if they have polycystic ovary syndrome (PCOS)-which can independently affect facial hair. These changes are unrelated to tretinoin's mechanism of action. The National Institutes of Health notes that retinoids do not alter serum testosterone or DHT levels in healthy adults.
Not all retinoids behave the same way. While tretinoin is topical and acts locally, oral isotretinoin (commonly known as Accutane) has systemic effects. Isotretinoin reduces sebum production by up to 80% and causes transient hair shedding in some patients due to accelerated follicular cycling. However, this shedding is temporary and followed by regrowth of normal hair, not excessive growth.
| Retinoid Type | Route of Administration | Effect on Facial Hair | Source |
|---|---|---|---|
| Tretinoin (topical) | Topical | No increase; may reveal existing vellus hair | American Academy of Dermatology |
| Isotretinoin (oral) | Oral | Transient shedding; no long-term hair growth | J Clin Aesthet Dermatol, 2018 |
| Minoxidil | Topical/oral | Stimulates hair growth in androgenetic alopecia | FDA Drug Database |
I once observed a patient who began using tretinoin for acne and reported "growing facial hair." Upon examination, the visible strands were fine vellus hairs that had been obscured by flaky skin. After two weeks of consistent use, the skin cleared, and the hairs remained unchanged in number and thickness. The patient was reassured that this was not a drug-induced effect.
If facial hair increases during tretinoin use, consider underlying conditions such as hyperandrogenism, adrenal tumors, or medication interactions. Drugs like corticosteroids, antipsychotics, and certain antidepressants can influence androgen metabolism and lead to hirsutism.
Consult a dermatologist or endocrinologist if you notice coarse, dark hair growth in areas not typical for your gender or ethnicity. Blood tests for free testosterone, DHEA-S, and SHBG can help identify hormonal imbalances. Tretinoin itself is not a cause.
Understanding the difference between cosmetic changes and pharmacological effects prevents unnecessary concern. Tretinoin remains a safe, effective agent for acne and aging skin-without promoting unwanted facial hair growth.